Chandigarh, January 2, 2026 – Nectar Lifesciences Limited (NECLIFE) saw a sharp surge in participation in its ongoing share buyback, with the issue reaching 0.95 times subscription as of 9:20 a.m. on January 2, 2026, bringing it close to full subscription midway through the offer period.
The company is undertaking a fixed-price buyback of up to 3 crore equity shares at an offer price of ₹27 per share, with the offer window running from December 31, 2025 to January 6, 2026.
Buyback SnapshotParticularsDetailsCompany NameNectar Lifesciences LimitedSymbolNECLIFESeriesBBOffer TypeBuybackIssue TypeFixed PriceOffer Price₹27 per equity shareFace Value₹1Issue SizeUp to 3,00,00,000 equity sharesOffer PeriodDecember...